Injective announces partnership with Andromeda
Injective announced a strategic partnership with Andromeda that will accelerate the adoption of DeFi by combining Andromeda's aOS and Injective's high-speed financial blockchain. Key highlights of the partnership include a seamless cross-chain portfolio, advanced DeFi applications, pass-through asset management and simplified segmentation of digital assets. The partnership will enhance cross-chain capabilities and simplify asset management, unlocking the full potential of next-generation Web3 applications.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Neola Medical wins US design patent for Neola user interface
Spinnova H1 FY26 operating loss narrows to EUR 6.89 million; revenue rises 186% to EUR 286,000
Crypto prices
More
